2024 ICD-10-CM Diagnosis Code B44.81

by

Allergic bronchopulmonary aspergillosis

  • B44.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B44.81 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B44.81 – other international versions of ICD-10 B44.81 may differ.

The following code(s) above B44.81 contain annotation back-references

 that may be applicable to B44.81:

  • A00-B99  Certain infectious and parasitic diseases
  • B35-B49  Mycoses
  • B44  Aspergillosis

Clinical Information

  • An immune reaction to aspergillus in patients usually suffering from asthma or cystic fibrosis.
  • Hypersensitivity reaction (allergic reaction) to fungus aspergillus in an individual with long-standing bronchial asthma. It is characterized by pulmonary infiltrates, eosinophilia, elevated serum immunoglobulin e, and skin reactivity to aspergillus antigen.

ICD-10-CM B44.81 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 196 Interstitial lung disease with mcc
  • 197 Interstitial lung disease with cc
  • 198 Interstitial lung disease without cc/mcc

Convert B44.81 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to B44.81: